Barlow Jeff D. 4
4 · MOLINA HEALTHCARE, INC. · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
Molina Healthcare (MOH) Chief Legal Officer Jeff Barlow Receives Award
What Happened Jeff D. Barlow, Chief Legal Officer of Molina Healthcare, received a grant of 13,722 restricted shares on March 1, 2026 valued at $145.75 per share (total ~$1,999,982). On the same date 1,638 shares were disposed (surrendered) at $154.05 each for $252,334 to satisfy withholding taxes related to the vesting of 4,183 shares.
Key Details
- Transaction dates and prices:
- 2026-03-01: Grant (Form 4 code A) — 13,722 RSU shares at $145.75 (VWAP for the 10 trading days prior) — $1,999,982 (F3, F4).
- 2026-03-01: Tax withholding (code F) — 1,638 shares withheld/disposed at $154.05 (closing price used) — $252,334 (F1, F2).
- Grant plan: Issued under the Company’s 2025 Equity Incentive Plan (F3).
- Vesting: The 13,722 newly granted shares vest in thirds on March 1 of 2027, 2028 and 2029. Additional (non-new) shares have scheduled vesting of 2,722 on 3/1/2027 and 1,619 on 3/1/2028; remaining shares noted as already vested (F5).
- Shares owned after the transactions: not specified in the filing.
- Filing timeliness: Report filed 2026-03-02 for transactions dated 2026-03-01 (appears timely).
Context This was primarily a restricted stock award (acquisition) — a common form of equity compensation. The small disposal was a routine cashless/share-surrender to cover tax withholding on vested shares, not an open-market sale. Awards and withholding like this are typical for executive compensation and should be viewed as compensation-related transactions rather than a direct bullish or bearish market signal.
Insider Transaction Report
- Tax Payment
Common Stock
[F1][F2]2026-03-01$154.05/sh−1,638$252,334→ 71,264 total - Award
Common Stock
[F3][F4][F5]2026-03-01$145.75/sh+13,722$1,999,982→ 84,986 total
Footnotes (5)
- [F1]The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,183 shares on March 1, 2026.
- [F2]Represents the closing price of the Issuer's common stock on February 27, 2026.
- [F3]Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.
- [F4]Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.
- [F5]The shares shall vest as follows: The 13,722 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 2,722 shares on March 1, 2027; and 1,619 shares on March 1, 2028. The remaining shares are vested.